News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Workday (WDAY) is back in focus after a strong Q2 FY2027 report beat Wall Street expectations and coincided with fresh payroll partnerships that extend its AI driven platform across U.S. and India payroll workflows. Workday’s recent payroll partnerships and AI push arrive after a sharp 69.1% 90 day share price return, even though the 1 year total shareholder return is down 20.34%. This suggests short term momentum has improved while longer term holders are still under water. Capitalize on...
Mondi’s updated fair value estimate has shifted from £8.45 to £8.86, which gives you a fresh reference point for thinking about the stock’s longer term price target. Recent research shows some analysts lifting targets toward 1,040 GBp while others move to more cautious levels such as 840 GBp and 750 GBp, so the gap between optimistic and neutral views is clear. In the sections that follow, you will see how these changing targets, and the news around Mondi, can help you track the evolving...
Asset manager dividends look safe until a bear market hits and fee revenue collapses with asset prices. The way these two giants earn their money means one of them faces a compounding threat that most income investors are not pricing in.
European equities traded in the US as American depositary receipts were tracking slightly lower Thur
Key Stats for Palo Alto Networks StockCurrent Price: $393. 30Target Price (Mid): ~$545Street Target (Mean): ~$396Potential Total Return: ~39%Annualized IRR: ~7% / yearWhat Happened?Palo Alto Networks (PANW) flagged 1,200 possible vulnerabilities across its own technology when Anthropic’s Mythos came out, and CEO Nikesh Arora said sorting real ones from false alarms and fixing them took three to four months.
Palantir Technologies (PLTR) stock has climbed 10.0% over the last five trading days, while the S&P 500 rose 2.0%. A run like that invites you to chase it. But one week is not the question. The question is what Palantir does to your money when the market moves, because it travels further than the index both ways and further still on the way down.
OpenAI and Anthropic quietly killed a deal to probe each other's AI models after it reached the contracts stage, and the reason it collapsed reveals a structural trap that no voluntary safety agreement can escape.
RXRX's strategic partnerships are expanding its drug pipeline, strengthening AI capabilities and providing non-dilutive funding through early 2028.
Everpure stock advances after the data-storage company says revenue growth will continue to accelerate in fiscal 2028.
Oracle's Project Jupiter could fail -- and it's not even Oracle's fault.
Centrus is securing deals to supply the fuel powering the next generation of nuclear reactors.
Over the past six months, Genesis Energy’s shares (currently trading at $14.67) have posted a disappointing 18.2% loss, well below the S&P 500’s 18.4% gain. This may have investors wondering how to approach the situation.
IonQ (NYSE:IONQ) has secured a contract to install its 256-qubit Superion quantum computer at Florida International University, marking the first sale and planned deployment of the system in Florida and expanding IonQ’s on-premises academic footprint. Key Investor TakeawaysIonQ (NYSE:IONQ) will deliver a Superion 256-qubit trapped-ion quantum computer to Florida International University under a new contract.
The market for blockchain-based bonds, funds and shares has almost quadrupled since early 2025 Deutsche Bank expects the market for tokenised financial assets to reach between $3 trillion and $4 trillion by 2035, up from about $25 billion last year. Tokenisation means recording ownership...
Key Stats for NVIDIA StockCurrent Price: $225. 51Target Price (Mid): ~$660Street Target: ~$328Potential Total Return: ~193%Annualized IRR: ~28% / yearWhat Happened?NVIDIA (NVDA) is paying nearly $13 billion for a company with about $150 million in revenue.
VanEck's concentrated 25-stock biotech portfolio surged 40.5% in one year, but Fidelity's diversified 365-holding fund delivered superior risk-adjusted returns with half the volatility.
Fervo Energy stock rises after the company’s geothermal development delivers power to the gid for the first time.
Meta just shattered Wall Street's consensus price target on the back of a 37% monthly surge, but with free cash flow collapsing 91% and capex ballooning toward $145 billion, the real debate is whether the AI spending spree pays off before it breaks the stock.
Accenture’s latest AI push comes as the stock remains about 32% lower this year and faces questions over consulting demand.
Key Stats for Carnival Corporation StockCurrent Price: $21. 80Target Price (Mid): ~$38Street Target: ~$34.
A quiet crisis is unfolding in the American housing market, where a collision of soaring mortgage rates, record home prices, and shrinking household budgets has locked millions of would-be buyers out of a market that may never look the same again.
MongoDB (MDB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
MYRG posts record Q2 earnings as higher revenues, stronger margins and a $3.16B backlog fuel growth.
Yahoo Finance Executive Editor Brian Sozzi breaks down the latest market movers and the day's biggest stories, while also sitting down with BlackRock's Rick Rieder to discuss the state of the bond market amid the latest sell-off.
Cost concerns have long challenged e-grocery, and addressing the issue is becoming more urgent as consumer price sensitivity rises, executives of the companies said.
Everpure (P) could sustain faster revenue growth and wider operating margins as it gains storage mar
Costco Wholesale Corp. (NASDAQ:COST) reports fiscal fourth-quarter earnings after the bell Thursday, with its earnings call scheduled for 5 p.m. ET. Wall Street expects earnings of about $6.53 per share, up from $5.87 a year ago. Costco has already reported...
Enterprise AI accounts for $165 of the bank’s SpaceX valuation, while rockets contribute only $8. The model depends on compute, connectivity and Tesla’s physical-AI capabilities.
InnoCare, which already has three approved therapies, describes itself as a biopharma focusing on cancer and autoimmune disease treatments.